Diabetes Mellitus, Lipoatrophic clinical trials

The registry lists 31 studies for Diabetes Mellitus, Lipoatrophic across more than 10 countries. 0 are recruiting or about to start. 2 of them are mainly about Diabetes Mellitus, Lipoatrophic (how this is decided). Per ClinicalTrials.gov, last updated 2021-06-03.

Status

Completed: 21
Terminated: 8
Status unknown: 2

Phase

Phase 3: 18
Phase 2: 8
Phase 4: 4

Where

United States: 12
Chile: 5
Germany: 4
Mexico: 4
Argentina: 3
Puerto Rico: 3

Who runs them

Takeda (27) · Kobe University (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Akcea Therapeutics (1)

What is being tested here

Drugs under test in Diabetes Mellitus, Lipoatrophic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Pioglitazone	9	16
Imiglitazar	6	6
Metformin	3	6
Insulin	1	3
Trelagliptin	0	2
Alogliptin	2	2
Empagliflozin	2	2
Vupanorsen	0	1
Metreleptin	0	1
Azilsartan	0	1

Drug classes tested here DPP-4 inhibitors 4

Who these studies take

No Diabetes Mellitus, Lipoatrophic study is recruiting now.

Across all 31 studies, recruiting or not: 35% stop at 75 or younger and 3% at 65; 3% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 31 of 31. search them.